The Therapeutic Role of Repetitive Transcranial Magnetic Stimulation in Children with Attention deficit/Hyperactivity Disorder in Egypt a Pilot Study

FACULTY OF MEDCINE AIN SHAMS UNIVERSITY0 个研究点目标入组 60 人开始时间: 2021年6月25日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Patients diagnosed with ADHD according to DSM IV
•Age ranges 7-12 years old
•All patients will be on the same type of medications throughout the duration of the study (Atomoxetine 1.2 mg/kg/day)

•Factors that might increase the risk of seizure with TMS such as a history of a seizure disorder, febrile seizures during childhood, known brain lesions, or a history of major head trauma involving loss of consciousness for more than 5 minutes.
•Specific contraindications to magnetic stimulation such as any metallic object implanted in the skull (with the exception of oral dental devices), an implanted medication pump or cochlear implant, implanted intra-cardiac lines or pacemaker.
•Comorbid diagnosis of autism spectrum disorder, bipolar disorder, obsessive-compulsive disorder, conduct disorder, Tourette disorder or other tic disorders, schizophrenia, schizoaffective disorder, or any other psychotic disorder.
•Any other neurological disorders.

发起方

FACULTY OF MEDCINE AIN SHAMS UNIVERSITY